🇺🇸 FDA
Patent

US 8101706

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

granted A61KA61K38/09A61K47/59

Quick answer

US patent 8101706 (Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/09, A61K47/59, A61P, A61P35/00